1 | Aavrh.10hfxn, serotype RH.10 adeno-associated virus (AAV) gene transfer vector expressing THE cdna coding FOR human FXN | - | - | - | - | 1件: 18 18 💬
|
2 | Alpha-tocotrienol quinone | 1件: Vatiquinone Vatiquinone | 1件: Vatiquinone
Vatiquinone
💬
| - | - | 3件: 18 18, 21, 156 💬
|
3 | Alpha-tocotrienolquinone | - | - | - | - | 1件: 18 18 💬
|
4 | Artesunate | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 4件: 18 18, 66, 86, 96 💬
|
5 | Artesunate oral product | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 2件: 18 18, 85 💬
|
6 | ASP2016 | - | - | - | - | 1件: 18 18 💬
|
7 | Baclofen | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 💬
|
8 | Balance training BY means OF conventional rehabilitation | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 18 18 💬
|
9 | Balance training over stabilometric platform | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 18 18 💬
|
10 | Binocrit*1SIR 40000UI/1ML | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 18 18 💬
|
11 | Blood analysis FOR frataxin'S level measurement | - | - | - | - | 1件: 18 18 💬
|
12 | Blood analysis FOR hypercalcemia'S control | - | - | - | - | 1件: 18 18 💬
|
13 | Bupropion & citalopram | 1件: Bupropion Bupropion | 3件: Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 18 18 💬
|
14 | Cabaletta FOR IV infusion once weekly during 24 weeks | 1件: Trehalose Trehalose | - | - | - | 1件: 18 18 💬
|
15 | Calcitriol | 1件: Calcitriol Calcitriol | 1件: Calcitriol
Calcitriol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 18 18, 37, 46, 49, 66, 96, 235, 326 💬
|
16 | CTI-1601 | 1件: CTI-1601 CTI-1601 | - | - | - | 1件: 18 18 💬
|
17 | Deferiprone | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 7件: 2 2, 6, 18, 121, 122, 139, 233 💬
|
18 | DT-216 | - | - | - | - | 1件: 18 18 💬
|
19 | DT-216p2 | - | - | - | - | 1件: 18 18 💬
|
20 | EGB 761 (R) 120 MG | - | - | - | - | 1件: 18 18 💬
|
21 | EGB 761 120 MG | - | - | - | - | 1件: 18 18 💬
|
22 | Elamipretide | 1件: Elamipretide Elamipretide | 2件: Elamipretide
Elamipretide
,
Elamipretide hydrochloride
💬
| - | - | 3件: 18 18, 21, 324 💬
|
23 | Epoeitin beta | - | - | - | - | 1件: 18 18 💬
|
24 | Epoetin alfa | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 3件: 13 13, 18, 46 💬
|
25 | Eprex*1FL 40000UI/ML 1ML | - | - | - | - | 1件: 18 18 💬
|
26 | Eprex*1SIR 10000UI 1ML | - | - | - | - | 1件: 18 18 💬
|
27 | Eprex*1SIR 40000UI/ML 1ML | - | - | - | - | 2件: 2 2, 18 💬
|
28 | Erythropoietin | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 10件: 2 2, 6, 13, 18, 22, 47, 61, 70, 95, 96 💬
|
29 | Etravirina | 1件: Etravirine Etravirine | 1件: Etravirine
Etravirine
💬
| - | - | 1件: 18 18 💬
|
30 | Etravirine tablets | 1件: Etravirine Etravirine | 1件: Etravirine
Etravirine
💬
| - | - | 1件: 18 18 💬
|
31 | EU1/97/031-032 | - | - | - | - | 1件: 18 18 💬
|
32 | EU1/97/031/031-032 | - | - | - | - | 1件: 18 18 💬
|
33 | Exercise intervention | - | - | - | - | 4件: 13 13, 18, 60, 97 💬
|
34 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: Flumazenil
Flumazenil
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 💬
|
35 | Gamma interferon | - | - | - | - | 1件: 18 18 💬
|
36 | Ginkgo biloba | 1件: Ginkgo biloba Ginkgo biloba | 1件: Ginkgo
Ginkgo
💬
| - | - | 3件: 13 13, 18, 47 💬
|
37 | Granocyte | - | - | - | - | 1件: 18 18 💬
|
38 | H-116PI-DE.PDF | - | - | - | - | 1件: 18 18 💬
|
39 | High dose LX2006 | - | - | - | - | 1件: 18 18 💬
|
40 | Idebenone | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 7件: 6 6, 8, 13, 18, 21, 113, 302 💬
|
41 | Imukin - 6 flaconi 0.5 ML 100 MCG | - | - | - | - | 2件: 18 18, 58 💬
|
42 | Imukin*SC 6F 0,5ML 100MCG | - | - | - | - | 1件: 18 18 💬
|
43 | Intelence - 200 MG - compressa -USO orale - flacone (hdpe) 60 compresse | 1件: Etravirine Etravirine | 1件: Etravirine
Etravirine
💬
| - | - | 1件: 18 18 💬
|
44 | Interferon gamma-1B | 2件: Interferon Gamma Interferon Gamma, Interferon gamma-1b | 1件: Interferon gamma-1b
Interferon gamma-1b
💬
| 2件: IFNGR1 IFNGR1, IFNGR2 💬
| 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 💬
|
45 | Iron chelating intervention | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 18 18 💬
|
46 | KPS-0373 | - | - | - | - | 1件: 18 18 💬
|
47 | KPS-0373, high dose | - | - | - | - | 1件: 18 18 💬
|
48 | KPS-0373, LOW dose | - | - | - | - | 1件: 18 18 💬
|
49 | Lenograstim | 1件: Lenograstim Lenograstim | 1件: Lenograstim
Lenograstim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 8件: 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
50 | Lithium carbonate | 2件: Lithium carbonate Lithium carbonate, Lithium citrate | 2件: Lithium carbonate
Lithium carbonate
,
Lithium citrate
💬
| - | - | 5件: 2 2, 13, 17, 18, 127 💬
|
51 | LOW dose LX2006 | - | - | - | - | 1件: 18 18 💬
|
52 | LU AA24493 | - | - | - | - | 1件: 18 18 💬
|
53 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
54 | MIB-626 | - | - | - | - | 1件: 18 18 💬
|
55 | MID dose LX2006 | - | - | - | - | 1件: 18 18 💬
|
56 | MIN-102 | - | - | - | - | 2件: 18 18, 20 💬
|
57 | NEO-recormon | - | - | - | - | 1件: 18 18 💬
|
58 | Neorecormon | 2件: Epoetin beta Epoetin beta, Erythropoietin | 5件: Epoetin alfa
Epoetin alfa
,
Epoetin beta
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 2件: 13 13, 18 💬
|
59 | Nicotinamide | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 5件: 6 6, 18, 49, 107, 162 💬
|
60 | Nicotinamide riboside | 3件: Nicotinamide Nicotinamide, Nicotinamide riboside, Zinc | 1件: Niacinamide
Niacinamide
💬
| - | - | 13件: 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
|
61 | Nomlabofusp | 1件: Nomlabofusp Nomlabofusp | - | - | - | 1件: 18 18 💬
|
62 | Omaveloxolone | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
63 | Omaveloxolone capsules, 10 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
64 | Omaveloxolone capsules, 150 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
65 | Omaveloxolone capsules, 160 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
66 | Omaveloxolone capsules, 2.5 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
67 | Omaveloxolone capsules, 20 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
68 | Omaveloxolone capsules, 300 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
69 | Omaveloxolone capsules, 40 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
70 | Omaveloxolone capsules, 5 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
71 | Omaveloxolone capsules, 80 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
72 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
73 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
74 | PTC743 | - | - | - | - | 2件: 18 18, 21 💬
|
75 | Resveratrol | 1件: Resveratrol Resveratrol | - | - | - | 5件: 8 8, 18, 89, 113, 299 💬
|
76 | RHUG-CSF | - | - | - | - | 1件: 18 18 💬
|
77 | Rokan (R) novo 120 MG | - | - | - | - | 1件: 18 18 💬
|
78 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 9件: 6 6, 18, 46, 49, 51, 79, 94, 96, 271 💬
|
79 | Saline | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 19件: 2 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
|
80 | SUB09246MIG | - | - | - | - | 1件: 18 18 💬
|
81 | TAK-831 | - | - | - | - | 1件: 18 18 💬
|
82 | Varenicline | 1件: Varenicline Varenicline | 2件: Varenicline tartrate
Varenicline tartrate
,
Varenicline
💬
| 2件: CHRNA4 CHRNA4, CHRNB2 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 2件: 6 6, 18 💬
|
83 | Vatiquinone | 1件: Vatiquinone Vatiquinone | 1件: Vatiquinone
Vatiquinone
💬
| - | - | 2件: 18 18, 21 💬
|